|
CN111303007A
|
|
Preparation method of (S) -5- (tert-butyloxycarbonyl) -5-azaspiro [2,4] heptane-6-carboxylic acid
|
|
CN111320535A
|
|
Preparation method of 3- (benzyloxy) -1-cyclobutanone
|
|
CN111205251A
|
|
Preparation method of chiral ligand (3S,4S) -2, 5-dioxy tetrahydrofuran-3, 4-bis-carbamic acid benzyl ester
|
|
CN111018803A
|
|
Preparation method of Barosavir intermediate
|
|
CN110423211A
|
|
A kind of preparation method for being adapted to industrialized production of 4- oxyindole
|
|
CN110218180A
|
|
The preparation method of 2,6- diamino -3,5- difluoro pyridine
|
|
CN108484566A
|
|
A kind of preparation method of ticagrelor key intermediate
|
|
CN107417629A
|
|
Aneurysm inhibitor XL784 preparation method
|
|
CN107188896A
|
|
A kind of oxygen bridge double-heptene class compound and its preparation and application containing resveratrol group
|
|
CN107474038A
|
|
One kind targeting ERs fluorescence probe and its preparation and application
|
|
CN106831726A
|
|
The preparation method of Internmediate of anti viral medicine benzodiazepine ketone derivatives
|
|
CN106831487A
|
|
The preparation method of organic electronic product intermediate fluorene kind derivative
|
|
CN107056760A
|
|
The preparation method of (3H) ketone derivatives of 1H benzos [e] [1,4] diaza 2 of 5,7 substitutions
|
|
CN106518823A
|
|
Preparation method of 4-(aminomethyl)-N-alkyltetrahydro-2H-furan-4-amine
|
|
CN106831538A
|
|
The preparation method of tropsch imatinib intermediate
|
|
CN106916134A
|
|
A kind of preparation method of 10,11- dihydros -5H- benzos [d] naphtho- [2,3-b] pyrone derivative
|
|
CN105523964A
|
|
Preparation method of anti-heart-failure drug intermediate
|
|
CN105061263A
|
|
Preparation method of NEP (neutral endopeptidase) inhibitor intermediate
|
|
CN103435523A
|
|
Preparation method for (1R, 2S)-2-fluoro-cyclopropanamine tosylate
|
